FR2426461A1 - Acides gras, derives de ceux-ci et medicaments qui en contiennent - Google Patents

Acides gras, derives de ceux-ci et medicaments qui en contiennent

Info

Publication number
FR2426461A1
FR2426461A1 FR7913122A FR7913122A FR2426461A1 FR 2426461 A1 FR2426461 A1 FR 2426461A1 FR 7913122 A FR7913122 A FR 7913122A FR 7913122 A FR7913122 A FR 7913122A FR 2426461 A1 FR2426461 A1 FR 2426461A1
Authority
FR
France
Prior art keywords
pharmaceutically acceptable
derivatives
fatty acids
products containing
amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913122A
Other languages
English (en)
French (fr)
Other versions
FR2426461B1 (nl
Inventor
Hans Olaf Bang
Jorn Dyerberg
John Robert Vane
Salvador Enrique Moncada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2426461A1 publication Critical patent/FR2426461A1/fr
Application granted granted Critical
Publication of FR2426461B1 publication Critical patent/FR2426461B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7913122A 1978-05-26 1979-05-23 Acides gras, derives de ceux-ci et medicaments qui en contiennent Granted FR2426461A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations

Publications (2)

Publication Number Publication Date
FR2426461A1 true FR2426461A1 (fr) 1979-12-21
FR2426461B1 FR2426461B1 (nl) 1983-02-11

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913122A Granted FR2426461A1 (fr) 1978-05-26 1979-05-23 Acides gras, derives de ceux-ci et medicaments qui en contiennent

Country Status (13)

Country Link
JP (1) JPS5515444A (nl)
AU (1) AU527784B2 (nl)
CA (1) CA1151068A (nl)
CH (1) CH644267A5 (nl)
DE (1) DE2831507A1 (nl)
ES (1) ES480921A0 (nl)
FR (1) FR2426461A1 (nl)
IE (1) IE48287B1 (nl)
IL (1) IL55227A (nl)
IT (1) IT1116505B (nl)
NL (1) NL191332C (nl)
NZ (1) NZ187908A (nl)
SE (1) SE448678B (nl)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542613A1 (fr) * 1983-03-18 1984-09-21 Terumo Corp Emulsion liquide pour transfusion
FR2614790A1 (fr) * 1987-05-07 1988-11-10 Scras Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
RU2538691C2 (ru) 2009-04-29 2015-01-10 Амарин Фарма, Инк. Стабильные фармацевтические композиции и способы их применения
LT3318255T (lt) 2009-06-15 2021-05-25 Amarin Pharmaceuticals Ireland Limited Kompozicijos ir būdai, skirti insulto gydymui pacientui kartu su statinų terapija
CA2775339C (en) 2009-09-23 2017-03-28 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
EP2775837A4 (en) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd METHODS OF TREATING HYPERTRIGLYCERIDEMIA
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
EP4342546A3 (en) 2012-06-29 2024-05-22 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
KR20150115745A (ko) 2013-02-06 2015-10-14 에이전시 포 사이언스, 테크놀로지 앤드 리서치 단백질 제제로부터 응집체 함량을 감소시키는 방법
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
FI4056176T3 (fi) 2018-09-24 2024-05-30 Amarin Pharmaceuticals Ie Ltd Menetelmät kardiovaskulaaristen tapahtumien riskin pienentämiseksi tutkittavassa

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5781M (nl) * 1965-03-27 1968-02-12
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
FR2231379A1 (nl) * 1973-05-30 1974-12-27 Cepbepe
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5781M (nl) * 1965-03-27 1968-02-12
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
FR2231379A1 (nl) * 1973-05-30 1974-12-27 Cepbepe
DE2749492A1 (de) * 1976-11-04 1978-05-11 Bio Oil Res Antithrombosemittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/61 *
EXBK/73 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542613A1 (fr) * 1983-03-18 1984-09-21 Terumo Corp Emulsion liquide pour transfusion
FR2614790A1 (fr) * 1987-05-07 1988-11-10 Scras Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique
BE1001075A3 (fr) * 1987-05-07 1989-06-27 Sod Conseils Rech Applic Nouvelle composition ophtalmologique.
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
WO1993020717A3 (en) * 1992-04-13 1994-02-17 Res Corp Technologies Inc Reducing gastrointestinal irritation in infant nutrition

Also Published As

Publication number Publication date
IT7947717A0 (it) 1979-01-19
IE48287B1 (en) 1984-11-28
IT1116505B (it) 1986-02-10
IL55227A0 (en) 1978-09-29
IL55227A (en) 1982-12-31
NL191332C (nl) 1995-06-01
DE2831507C2 (nl) 1989-07-13
AU3808478A (en) 1980-01-17
JPS5515444A (en) 1980-02-02
IE791023L (en) 1979-11-26
NL7904144A (nl) 1979-11-28
ES8104983A1 (es) 1981-05-16
CH644267A5 (en) 1984-07-31
FR2426461B1 (nl) 1983-02-11
SE7904570L (sv) 1979-11-27
CA1151068A (en) 1983-08-02
NZ187908A (en) 1984-05-31
ES480921A0 (es) 1981-05-16
DE2831507A1 (de) 1979-11-29
SE448678B (sv) 1987-03-16
NL191332B (nl) 1995-01-02
AU527784B2 (en) 1983-03-24

Similar Documents

Publication Publication Date Title
FR2426461A1 (fr) Acides gras, derives de ceux-ci et medicaments qui en contiennent
NL193459B (nl) Vetzuursamenstelling met omega-3-poly-onverzadigde vetzuren, werkwijze voor de bereiding ervan en farmaceutische samenstelling op basis daarvan.
PT64840A (fr) Procede de preparation d'esteres aralquiliques d'acide 1,4-dihydrapiridinocarboxilique a effet coronaire et antihypertensive application des memes pour la preparation de compositions pharmaceutiques a effet coronaire et antihypertensive et application de ces compositions pharmaceutiques pour le traitement de maladies de lacirculation sanguine
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE69004817D1 (de) Zusammensetzung und Verfahren zur Behandlung von Erkrankungen.
PT79648B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
EP0302481A3 (en) Use of free fatty acids for the manufacture of a medicament for treatment of diabetes mellitus
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
SE8800989D0 (sv) Dietary composition and process for preparing same
JPS56110679A (en) 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
DE3062300D1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them
AT301548B (de) Verfahren zur Herstellung von neuen (1,2,3,4-Tetrahydro-6-chinolyl)-essigsäuren, deren Estern und stickstoffhaltigen Derivaten, sowie deren Isomeren, optischen Antipoden und Salzen
AT289752B (de) Verfahren zur Herstellung von neuen 4-Aminomethylbicyclo[2,2,2]octan- bzw. 4-Aminomethylbicyclo[3,2,2]nonan-1-carbonsäuren und deren 2,5-Diketoverbindungen, sowie deren Salzen, Estern und N-Alkanoylverbindungen
FR2302727A1 (fr) Nouveaux derives d'acide prostanique, leur procede de preparation et leur application en tant que medicaments
AT298444B (de) Verfahren zur Herstellung der neuen 4-Aminomethylbicyclo[2,2,1]heptan-1-carbonsäure und deren Salze, Ester und N-Alkanoylderivate
FR2627487B1 (fr) Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant
AT325041B (de) Verfahren zur herstellung neuer ungesättigter, äthersubstituierter xanthoncarbonsäurederivate und deren pharmazeutisch zulässigen estern, amiden und salzen
FR1271960A (fr) Procédé pour la préparation de composés aliphatiques non satures, notamment d'acides et de leurs esters
SE8800101L (sv) Anvaendning av essentiella fettsyror foer framstaellning av ett preparat foer behandling av eksem
GR59324B (en) 4-biphenylacetic acid as an inhibitor of blood platelet aggregation and preparation process thereof
FR1337496A (fr) Procédé de sulfonation d'acides gras et de leurs dérivés, en particulier d'esters d'acides gras

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property